A translational approach to detecting drug-induced cardiac injury with cardiac troponins: Consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute-Reference-Cited by-同舟云学术

A translational approach to detecting drug-induced cardiac injury with cardiac troponins: Consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute

Published:2009-07 Issue:1 Volume:158 Page:21-29
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Berridge Brian R.,Pettit Syril,Walker Dana B.,Jaffe Alan S.,Schultze Albert E.,Herman Eugene,Reagan William J.,Lipshultz Steven E.,Apple Fred S.,York Malcolm J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Why drugs fail—a study on side effects in new chemical entities;Schuster;Curr Pharm Des,2005

2. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005;Moore;Arch Intern Med,2007

3. Serum troponins as biomarkers of drug-induced cardiac toxicity;Wallace;Toxicol Pathol,2004

4. Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker;O'Brien;Expert Rev Mol Diag,2006

5. Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity;O'Brien;Toxicology,2008

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical cardiovascular safety assessment of pharmacology-toxicology relationship for a set of novel kinase inhibitors;Toxicological Sciences;2024-01-08

2. Clinical Pathology in Nonclinical Toxicity Studies;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

3. Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide;European Heart Journal Open;2023-12-08

4. Differentiating Cardiac Troponin Levels During Cardiac Myosin Inhibition or Cardiac Myosin Activation Treatments: Drug Effect or the Canary in the Coal Mine?;Current Heart Failure Reports;2023-10-25

5. Maximum Tolerated Dose (MTD) Studies in Drug Toxicology Assessments;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2023